Cite
MLA Citation
Carmel Collins et al.. “The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.” BMC pediatrics, vol. 16, no. 1, 2016, pp. 1–9. http://access.bl.uk/ark:/81055/vdc_100080460865.0x00011d